We are live on ! Find out more
PRQR icon

ProQR Therapeutics
PRQR

51 hedge funds and large institutions have $17.2M invested in ProQR Therapeutics in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,088% more call options, than puts

Call options by funds: $95K | Put options by funds: $8K

12% less funds holding

Funds holding: 58 → 51 (-7)

13% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 16

13.56% less ownership

Funds ownership: 44.61% → 31.05% (-14%)

39% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 18

39% less capital invested

Capital invested by funds: $28.2M → $17.2M (-$11M)

Holders
51
Holders Change
-7
Holders Change %
-12.07%
% of All Funds
0.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
14
Reduced
16
Closed
18
Calls
$95K
Puts
$8K
Net Calls
+$87K
Net Calls Change
-$1.51M

Top Buyers

Rank Fund Capital Flow
1
PM
Prosight Management
Texas
+$826K
2
MAM
Monaco Asset Management
Monaco
+$627K
3
Renaissance Technologies
Renaissance Technologies
New York
+$242K
4
OM
Opaleye Management
Massachusetts
+$235K
5
Citadel Advisors
Citadel Advisors
Florida
+$156K

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$6.35M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$2.79M
3
Goldman Sachs
Goldman Sachs
New York
-$459K
4
Millennium Management
Millennium Management
New York
-$443K
5
CAC
Cowen and Company
New York
-$342K
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Advisers
26
Two Sigma Advisers
New York
$43K -$56.5K -75,800 -58%
State Street
27
State Street
Massachusetts
$41K -$109K -146,534 -74%
HF
28
HRT Financial
New York
$36K +$34.6K +46,469 New
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
$31K +$29.5K +39,565 New
Geode Capital Management
30
Geode Capital Management
Massachusetts
$28K – – –
Bank of America
31
Bank of America
North Carolina
$27K +$11.1K +14,946 +76%
AI
32
Atom Investors
Texas
$24K – – –
TSS
33
Two Sigma Securities
New York
$22K +$10.3K +13,880 +100%
Osaic Holdings
34
Osaic Holdings
Arizona
$17K – – –
GSC
35
Ground Swell Capital
South Carolina
$17K +$16.1K +21,640 New
TRCT
36
Tower Research Capital (TRC)
New York
$14K +$11.8K +15,895 +703%
VPIM
37
Vanguard Personalized Indexing Management
California
$13K +$3.99K +5,348 +47%
CHAM
38
Clear Harbor Asset Management
Connecticut
$13K +$12.7K +17,000 New
BCM
39
Bayesian Capital Management
New York
$10K -$298 -400 -3%
Wells Fargo
40
Wells Fargo
California
$9K – – –
AG
41
Algert Global
California
$8K -$481 -645 -6%
KAS
42
Kestra Advisory Services
Texas
$8K -$373 -500 -5%
CAPTRUST Financial Advisors
43
CAPTRUST Financial Advisors
North Carolina
$6K +$5.59K +7,500 New
CG
44
Cutler Group
California
$5K -$6.11K -8,200 -53%
Zurich Cantonal Bank
45
Zurich Cantonal Bank
Switzerland
$3K – – –
BNP Paribas Financial Markets
46
BNP Paribas Financial Markets
France
$2.34K +$2.25K +3,014 New
Citigroup
47
Citigroup
New York
$1K -$7.49K -10,051 -89%
BHWM
48
Beaird Harris Wealth Management
Texas
$1K – – –
RI
49
RTW Investments
New York
– -$6.35M -7,019,610 Closed
Wellington Management Group
50
Wellington Management Group
Massachusetts
– -$2.79M -3,084,150 Closed
1
2
3

PRQR Hedge Fund Activity: Q2 2022 in Review

51 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q2 2022, worth a combined $17.2M — down 39% from $28.2M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of PRQR and 11 opened new positions — a net loss of 7 holders — while 16 trimmed existing stakes and 14 added.

The largest buyer was Prosight Management, adding an estimated $826K. The largest seller was RTW Investments, exiting entirely with an estimated $6.35M sold.

  • 51 institutional investors held ProQR Therapeutics (PRQR) as of Q2 2022, down from 58 in Q1 2022.
  • Funds reported $17.2M of ProQR Therapeutics stock for Q2 2022, down 39% quarter-over-quarter.
  • 11 funds opened new ProQR Therapeutics positions in Q2 2022 and 18 closed out, a net change of -7 holders.
  • The largest ProQR Therapeutics buyer in Q2 2022 was Prosight Management, an estimated $826K added.
  • The largest ProQR Therapeutics seller in Q2 2022 was RTW Investments, an estimated $6.35M sold.

Based on aggregated 13F filings for Q2 2022.